Literature DB >> 28854547

Using a worldwide in-app survey to explore sugammadex usage patterns: a prospective observational study.

V N O'Reilly-Shah1, F A Wolf1, C S Jabaley1, G C Lynde1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28854547     DOI： 10.1093/bja/aex171

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  9 in total

1.  Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis.

Authors:  Sachin Kheterpal; Michelle T Vaughn; Timur Z Dubovoy; Nirav J Shah; Lori D Bash; Douglas A Colquhoun; Amy M Shanks; Michael R Mathis; Roy G Soto; Amit Bardia; Karsten Bartels; Patrick J McCormick; Robert B Schonberger; Leif Saager
Journal:  Anesthesiology       Date:  2020-06       Impact factor: 7.892

2.  Utilization Patterns of Perioperative Neuromuscular Blockade Reversal in the United States: A Retrospective Observational Study From the Multicenter Perioperative Outcomes Group.

Authors:  Timur Z Dubovoy; Leif Saager; Nirav J Shah; Douglas A Colquhoun; Michael R Mathis; Steven Kapeles; Graciela Mentz; Sachin Kheterpal; Michelle T Vaughn
Journal:  Anesth Analg       Date:  2020-11       Impact factor: 6.627

3.  Factors influencing healthcare provider respondent fatigue answering a globally administered in-app survey.

Authors:  Vikas N O'Reilly-Shah
Journal:  PeerJ       Date:  2017-09-12       Impact factor: 2.984

4.  Initial experience with the unrestricted introduction of sugammadex at a large academic medical center: a retrospective observational study examining postoperative mechanical ventilation and efficiency outcomes.

Authors:  Vikas N O'Reilly-Shah; Grant C Lynde; Matthew L Mitchell; Carla L Maffeo; Craig S Jabaley; Francis A Wolf
Journal:  Korean J Anesthesiol       Date:  2018-05-30

5.  A comparison between cisatracurium and rocuronium-induced neuromuscular block on laryngeal electromyography recovery after neostigmine reversal in a porcine model.

Authors:  I-Cheng Lu; Hao Tan; Sheng-Hua Wu; Tzu-Yen Huang; Hsin-Yi Tseng; Jia-Joanna Wang; Gianlorenzo Dionigi; Young Jun Chai; Feng-Yu Chiang; Pi-Ying Chang; Che-Wei Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

6.  Administration of neostigmine after tracheal intubation shortens time to successful intraoperative neuromonitoring during thyroid surgery: a randomized controlled trial.

Authors:  Moon Young Oh; Young Jun Chai; Tzu-Yen Huang; Che-Wei Wu; Gianlorenzo Dionigi; Hoon Yub Kim; Chanho Kim; Dongwook Won; Jung-Man Lee
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

7.  Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study.

Authors:  Craig S Jabaley; Francis A Wolf; Grant C Lynde; Vikas N O'Reilly-Shah
Journal:  Ther Adv Drug Saf       Date:  2018-04-18

Review 8.  Sugammadex: Appropriate Use in the Context of Budgetary Constraints.

Authors:  Guy Cammu
Journal:  Curr Anesthesiol Rep       Date:  2018-03-20

9.  Rapid Sequence Induction With a Standard Intubation Dose of Rocuronium After Magnesium Pretreatment Compared With Succinylcholine: A Randomized Clinical Trial.

Authors:  Christoph Czarnetzki; Eric Albrecht; Philippe Masouyé; Moira Baeriswyl; Antoine Poncet; Matthias Robin; Christian Kern; Martin R Tramèr
Journal:  Anesth Analg       Date:  2021-12-01       Impact factor: 6.627
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.